Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through RNA sequencing analysis
Abstract Background With demographic shifts toward older populations, the number of people with dementia is steadily increasing. Alzheimer’s disease (AD) is the most common cause of dementia, and no curative treatment is available. The current best strategy is to delay disease progression and to pra...
Main Authors: | Daichi Shigemizu, Taiki Mori, Shintaro Akiyama, Sayuri Higaki, Hiroshi Watanabe, Takashi Sakurai, Shumpei Niida, Kouichi Ozaki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13195-020-00654-x |
Similar Items
-
Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer’s disease created by integrative analysis of multi-omics data
by: Daichi Shigemizu, et al.
Published: (2020-11-01) -
Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.
by: Risa Mitsumori, et al.
Published: (2020-01-01) -
A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer’s disease
by: Yuya Asanomi, et al.
Published: (2019-06-01) -
Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer’s disease patients
by: Risa Mitsumori, et al.
Published: (2020-01-01) -
Classification and deep-learning–based prediction of Alzheimer disease subtypes by using genomic data
by: Daichi Shigemizu, et al.
Published: (2023-06-01)